Baxter International | BAX - Pre Tax Profit


Baxter International reported $-756M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Avanos Medical USD 1.2M 2.4M Dec/2025
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 192.2M 75.4M Dec/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Fresenius EUR 601M 122M Dec/2025
Globus Medical USD 169.23M 25.24M Dec/2025
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
ICU Medical USD -15.9M 86.2M Dec/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Laboratory Of America USD 8.73B 8.54B Mar/2026
Medtronic USD 2.45B 1.04B Mar/2026
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Smith & Nephew USD 469M 70M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
Terumo JPY 31.67B 13.71B Mar/2026
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025